Your browser doesn't support javascript.
COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations.
Lunn, Michael P; Cornblath, David R; Jacobs, Bart C; Querol, Luis; van Doorn, Peter A; Hughes, Richard A; Willison, Hugh J.
  • Lunn MP; 1 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
  • Cornblath DR; 2 Department of Neuromuscular Disease, Institute of Neurology, University College London, WC1N 3BG, UK.
  • Jacobs BC; 3 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Querol L; 4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Doorn PA; 5 Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Hughes RA; 6 Department of Neurology, Hospital de la Santa Creu I Santa Pau, 8025, Barcelona, Spain.
  • Willison HJ; 4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Brain ; 144(2): 357-360, 2021 03 03.
Article in English | MEDLINE | ID: covidwho-975206
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Brain Year: 2021 Document Type: Article Affiliation country: Brain

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Brain Year: 2021 Document Type: Article Affiliation country: Brain